AU2013277959B2 - Purification of virus like particles - Google Patents

Purification of virus like particles Download PDF

Info

Publication number
AU2013277959B2
AU2013277959B2 AU2013277959A AU2013277959A AU2013277959B2 AU 2013277959 B2 AU2013277959 B2 AU 2013277959B2 AU 2013277959 A AU2013277959 A AU 2013277959A AU 2013277959 A AU2013277959 A AU 2013277959A AU 2013277959 B2 AU2013277959 B2 AU 2013277959B2
Authority
AU
Australia
Prior art keywords
vlps
solution
norovirus
subpopulation
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013277959A
Other languages
English (en)
Other versions
AU2013277959A1 (en
Inventor
Ross Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Vaccines Inc
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Publication of AU2013277959A1 publication Critical patent/AU2013277959A1/en
Application granted granted Critical
Publication of AU2013277959B2 publication Critical patent/AU2013277959B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2013277959A 2012-06-22 2013-06-24 Purification of virus like particles Active AU2013277959B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261663218P 2012-06-22 2012-06-22
US61/663,218 2012-06-22
US201361794086P 2013-03-15 2013-03-15
US61/794,086 2013-03-15
PCT/US2013/047249 WO2013192604A1 (en) 2012-06-22 2013-06-24 Purification of virus like particles

Publications (2)

Publication Number Publication Date
AU2013277959A1 AU2013277959A1 (en) 2015-01-22
AU2013277959B2 true AU2013277959B2 (en) 2019-05-16

Family

ID=49769461

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013277959A Active AU2013277959B2 (en) 2012-06-22 2013-06-24 Purification of virus like particles

Country Status (15)

Country Link
US (3) US10167320B2 (cg-RX-API-DMAC7.html)
EP (1) EP2864478B1 (cg-RX-API-DMAC7.html)
JP (1) JP6553509B2 (cg-RX-API-DMAC7.html)
KR (1) KR102110876B1 (cg-RX-API-DMAC7.html)
CN (2) CN104583393A (cg-RX-API-DMAC7.html)
AR (1) AR091538A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013277959B2 (cg-RX-API-DMAC7.html)
CA (1) CA2879815A1 (cg-RX-API-DMAC7.html)
IN (1) IN2015DN00089A (cg-RX-API-DMAC7.html)
JO (1) JOP20130186B1 (cg-RX-API-DMAC7.html)
MX (1) MX366234B (cg-RX-API-DMAC7.html)
SG (2) SG11201408459VA (cg-RX-API-DMAC7.html)
TW (1) TWI647310B (cg-RX-API-DMAC7.html)
UY (1) UY34875A (cg-RX-API-DMAC7.html)
WO (1) WO2013192604A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007303608B2 (en) 2006-09-29 2013-05-02 Takeda Vaccines, Inc. Norovirus vaccine formulations
WO2008113011A2 (en) 2007-03-14 2008-09-18 Ligocyte Pharmaceuticals, Inc. Virus like particle purification
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
EA202090699A3 (ru) 2011-07-11 2020-11-30 Такеда Вэксинс, Инк. Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
CN105339495A (zh) * 2013-07-11 2016-02-17 宝生物工程株式会社 制备无包膜病毒的方法
US10501500B2 (en) 2013-10-03 2019-12-10 Takeda Vaccines, Inc. Methods of detection and removal of rhabdoviruses from cell lines
CN103981084B (zh) * 2014-05-29 2015-11-18 黑龙江省科学院微生物研究所 水中病毒分离提取装置及水中札幌病毒的提取方法
US10415020B2 (en) 2015-01-09 2019-09-17 Takara Bio Inc. Method for producing non-enveloped viral particles
EP3245306A4 (en) * 2015-01-16 2018-09-05 Takeda Vaccines, Inc. Detection of particle-contained reverse transcriptase activity
CN105907729B (zh) * 2015-05-05 2019-08-16 广东东阳光药业有限公司 一种制备人乳头瘤病毒l1蛋白类病毒样颗粒的方法
CN107034198B (zh) * 2015-07-15 2021-03-09 长春百克生物科技股份公司 一种嵌合诺如病毒p颗粒及其制备和应用
MX2018002419A (es) * 2015-08-28 2018-11-29 Ology Bioservices Inc Vacuna de norovirus.
CN105779399A (zh) * 2016-03-28 2016-07-20 广西壮族自治区林业科学研究院 一种昆虫杆状病毒纯化方法
GB201614050D0 (en) * 2016-08-17 2016-09-28 Glaxosmithkline Ip Dev Ltd Method for purifying viral vectors
CN109689092A (zh) * 2016-09-01 2019-04-26 武田疫苗股份有限公司 用于产生用于疫苗生产的病毒的方法
EP3420076B1 (en) * 2017-03-06 2024-02-21 Guangzhou Realbenefitspot Pharmaceutical Co., Ltd. Methods of producing and characterizing virus vaccine and virus vaccine composition
ES2975182T3 (es) 2017-03-06 2024-07-03 Guangzhou Realbenefitspot Pharmaceutical Co Ltd Métodos de producción y caracterización de vacunas víricas y composición de vacuna vírica
EP3752185A1 (en) 2018-02-15 2020-12-23 Icon Genetics GmbH Immunogenic composition and vaccine for generating an immune response to norovirus
CN108676781A (zh) * 2018-05-18 2018-10-19 山东信得动物疫苗有限公司 一种重组禽流感病毒的工业化纯化方法
CN108776225A (zh) * 2018-05-23 2018-11-09 中国农业科学院兰州兽医研究所 猪细小病毒VLPs抗体检测试剂盒及其制备方法、应用
CA3133030A1 (en) 2019-03-12 2020-09-17 Icon Genetics Gmbh Norovirus-like particles with improved stability
JP2022549932A (ja) 2019-09-30 2022-11-29 バイオベラティブ セラピューティクス インコーポレイテッド レンチウイルスベクター製剤
WO2022246323A1 (en) 2021-05-21 2022-11-24 Takeda Vaccines, Inc. Solid composition, freeze-drying method and glass vial
KR20240026204A (ko) * 2021-06-28 2024-02-27 브이에스티 엘엘씨 디비에이 메디진 랩스 사포바이러스 백신
CN116789773B (zh) * 2022-11-30 2024-02-20 华北制药金坦生物技术股份有限公司 一种胞内表达病毒样颗粒的粗纯方法
WO2025077800A1 (en) * 2023-10-12 2025-04-17 Chengdu Kanghua Biological Products Co., Ltd. Purification of norovirus virus-like particles (vlps)
CN118126202B (zh) * 2024-05-07 2024-07-30 上海瑞宙生物科技有限公司 一种诺如病毒类病毒颗粒及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080781A1 (en) * 2007-12-21 2009-07-02 Cytos Biotechnology Ag Process for clarifying cell homogenates
CN102260651A (zh) * 2011-06-24 2011-11-30 华中科技大学同济医学院附属协和医院 一种纯化病毒样颗粒蛋白的方法及其应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2833106B2 (ja) 1990-02-21 1998-12-09 株式会社島津製作所 液体クロマトグラフ
WO1994026087A2 (en) 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
PL183781B1 (pl) 1994-05-16 2002-07-31 Merck & Co Inc Sposób wytwarzania szczepionki przeciwko ludzkiemu wirusowi brodawczaków
AR004464A1 (es) 1994-11-14 1998-12-16 Merck Sharp & Dohme Un metodo para producir una proteina de capside de papilomavirus
JP3316325B2 (ja) 1994-12-20 2002-08-19 富士シリシア化学株式会社 ビール安定化処理用シリカゲル及びその製造方法並びにビールの安定化処理方法
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
ATE423204T1 (de) 1996-11-08 2009-03-15 Us Gov Health & Human Serv Herstellung und reinigung von hepatitis c virus- ähnlichen partikeln
EP1015561B1 (en) 1997-09-05 2006-07-19 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
DE19823814A1 (de) 1998-05-27 1999-12-02 Octapharma Ag Ziegelbruecke Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie
ATE324436T1 (de) 1998-08-14 2006-05-15 Merck & Co Inc Verfahren zur reinigung von menschlichen, dem papillomavirus ähnlichen partikeln.
ES2313881T3 (es) * 1999-02-05 2009-03-16 MERCK & CO., INC. Formulaciones de vacunas frente al papilomavirus humano.
US6349843B1 (en) 1999-04-01 2002-02-26 The Vollrath Company Llc Pan removal ramp
WO2000079280A1 (en) 1999-06-22 2000-12-28 Japan As Represented By Director-General National Institute Of Infectious Diseases Srsv detection kit
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP2003066021A (ja) 2001-08-28 2003-03-05 Hiroshi Shionoya 連続分取液体クロマトグラフィー装置とそれを用いる方法
WO2003068933A2 (en) 2002-02-14 2003-08-21 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
DK1501369T3 (en) 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
AU2003268210A1 (en) 2002-08-28 2004-03-19 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
US7879338B2 (en) 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
US7481997B1 (en) 2004-02-12 2009-01-27 Montana State University Snow mountain virus genome sequence, virus-like particles and methods of use
US8277819B2 (en) 2005-06-16 2012-10-02 Children's Hospital Medical Center Norovirus particle for use as an antiviral or vaccine
EP1736538A1 (en) 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
JP5215865B2 (ja) 2005-11-22 2013-06-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド ノロウイルス抗原およびサポウイルス抗原
MY180002A (en) 2005-12-29 2020-11-19 Boehringer Ingelheim Vetmedica Inc Multivalent pcv2 immunogenic compositions and methods of producing compositions
CA2659275C (en) 2006-07-27 2017-01-10 Ligocyte Pharmaceuticals, Inc. Chimeric influenza virus-like particles
AU2007303608B2 (en) 2006-09-29 2013-05-02 Takeda Vaccines, Inc. Norovirus vaccine formulations
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
WO2008113011A2 (en) * 2007-03-14 2008-09-18 Ligocyte Pharmaceuticals, Inc. Virus like particle purification
EP2027875A1 (en) 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
US10130696B2 (en) * 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
SG2013057732A (en) 2008-08-08 2015-02-27 Ligocyte Pharmaceuticals Inc Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
EP2362901A1 (en) 2008-11-03 2011-09-07 Ligocyte Pharmaceuticals, Inc. Improved methods for isolating enveloped virus-based vlps free of infectious agents
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US8980275B2 (en) 2010-01-21 2015-03-17 Takeda Vaccines, Inc. Targeted heterologous antigen presentation on calicivirus virus-like particles
WO2012040216A1 (en) * 2010-09-20 2012-03-29 Bio-Rad Laboratories, Inc. Dissociation of product-complexed contaminants in chromatography
FI122520B (fi) 2010-10-15 2012-03-15 Vesna Blazevic Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
JP2015015931A (ja) 2013-07-12 2015-01-29 株式会社Ｕｍｎファーマ ウイルス様粒子を含む培養物の製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080781A1 (en) * 2007-12-21 2009-07-02 Cytos Biotechnology Ag Process for clarifying cell homogenates
CN102260651A (zh) * 2011-06-24 2011-11-30 华中科技大学同济医学院附属协和医院 一种纯化病毒样颗粒蛋白的方法及其应用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AUSAR, S.F. et al., ‘Conformational Stability and Disassembly of Norwalk Virus-like Particles. Effect of pH and temperature.’ The Journal of Biological Chemistry. 2006 , vol.281, no.28, pages 19478-19488 *
BRORSON, K et al., ‘Bracketed Generic Inactivation of Rodent Retroviruses by Low pH Treatment for Monoclonal Antibodies and Recombinant Proteins’, Biotechnology and Bioengineering. 2003, vol.82, no.3, pages 321-329 *
DIKA, C. et al., 'Impact of Internal RNA on Aggregation and Electrokinetics of Viruses: Comparison between MS2 Phage and Corresponding Virus-Like Particles' Applied and Environmental Microbiology. July 2011, vol.77, no.14, pages 4939-4948 *
HUHTI L ET AL, "A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles", ARCHIVES OF VIROLOGY, (2010-08-19), vol. 155, no. 11, pages 1855 - 1858 *
LAU, A et al., ‘Quantitative competitive reverse transcription-PCR as a method to evaluate retrovirus removal during chromatography procedures’, Journal of Biotechnology. 1999, vol.75, pages 105-115 *
LYDERSEN B. K et al., ‘Acid precipitation of mammalian cell fermentation broth’, Annals of the New York Academy of Sciences. 1994, vol.745, pages 222-31 *
MIESEGAES, G. et al., ‘Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies’, Biotechnology and Bioengineering. 2010, vol.106, no.2, pages 238-246 *
VINCENTE, T. et al., ‘Large-scale production and purification of VLP-based vaccines’, Journal of Invertebrate Pathology. 2011, vol.107, pages S42–S48 *

Also Published As

Publication number Publication date
EP2864478A4 (en) 2015-12-02
US20220213147A1 (en) 2022-07-07
US10167320B2 (en) 2019-01-01
AU2013277959A1 (en) 2015-01-22
CA2879815A1 (en) 2013-12-27
IN2015DN00089A (cg-RX-API-DMAC7.html) 2015-05-29
EP2864478A1 (en) 2015-04-29
SG10201610753YA (en) 2017-02-27
UY34875A (es) 2013-12-31
WO2013192604A1 (en) 2013-12-27
US20190169236A1 (en) 2019-06-06
MX2014015842A (es) 2015-09-07
JP2015521628A (ja) 2015-07-30
KR20150051988A (ko) 2015-05-13
US12286456B2 (en) 2025-04-29
US20140004145A1 (en) 2014-01-02
AR091538A1 (es) 2015-02-11
CN114085273A (zh) 2022-02-25
MX366234B (es) 2019-07-03
TWI647310B (zh) 2019-01-11
CN114085273B (zh) 2024-07-12
JP6553509B2 (ja) 2019-07-31
CN104583393A (zh) 2015-04-29
SG11201408459VA (en) 2015-01-29
US11091519B2 (en) 2021-08-17
KR102110876B1 (ko) 2020-05-14
EP2864478B1 (en) 2020-12-09
JOP20130186B1 (ar) 2021-08-17
TW201406956A (zh) 2014-02-16
HK1210210A1 (en) 2016-04-15

Similar Documents

Publication Publication Date Title
US12286456B2 (en) Purification of virus like particles
JP7792339B2 (ja) コロナウイルスワクチン製剤
CN105745218B (zh) 去除残留细胞培养杂质
CA2423038A1 (en) Live vaccine and method of manufacture
US6149917A (en) Industrial production process for a vaccine against Japanese encephalitis virus and vaccine produced
CN1230197A (zh) 呼吸道合胞体病毒亚基疫苗制剂
EP0480949A1 (en) PRODUCTION OF A VIRUS AND CLEANING OF VIRUS COATING PROTEINS FOR VACCINE USE.
CN105018435A (zh) 一种病毒样颗粒的纯化方法
JP4523164B2 (ja) ワクチン
HK1210210B (en) Purification of virus like particles
FI97058C (fi) Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi
CN116554281A (zh) 一种口蹄疫病毒衣壳蛋白病毒样颗粒的纯化方法
RU2120804C1 (ru) Способ приготовления вакцины против клещевого или японского энцефалита из вирусной суспензии
US7344839B2 (en) Virus preparations and methods
AU732951B2 (en) Parainfluenza virus glycoproteins and vaccines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)